| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,786 | 20,747 | 19,948 | 21,583 | | Cost of Revenue | 6,886 | 7,128 | 7,686 | 9,081 | | | Gross Profit | 12,900 | 13,619 | 12,262 | 12,502 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 73,014 | 12,704 | 11,031 | 7,674 | | Non Recurring | 259 |
-
|
-
| (40) | | Others | 25,719 | 9,764 | 6,693 | 19,304 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (86,092) | (8,849) | (5,462) | (14,436) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (86,092) | (8,849) | (5,462) | (14,436) | | Interest Expense | 1,492 | 1,508 | 1,512 | 1,557 | | Income Before Tax | (87,584) | (10,357) | (6,974) | (15,993) | | Income Tax Expense | (9,504) | (3,857) | (2,601) | (5,979) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (78,080) | (6,500) | (4,373) | (10,014) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (78,080) | (6,500) | (4,373) | (10,014) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($78,080) | ($6,500) | ($4,373) | ($10,014) |
|
0.31% Nasdaq 
0.05%
Income Statement
